Clinical trial · Observational
Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of Indicators
Multicentric Evaluation of COVID-19 Impact on Cancer Patients' Diagnostic and Management: Set-up of Indicators to Follow-up the Activities of Different Cancer Pathologies
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The COVID-19 pandemic has deeply and globally impacted usual procedures and patients management in cancer centers. The aim of this study is to set-up and collect indicators to follow-up the activities of different cancer pathologies before and during the pandemic. Patients loss' of chance will be analysed in term of diagnosis and access to care (surgery, antineoplastic treatments). Data collection will focus on the analysis of 2 specific pathologies for French patients in the "Auvergne-Rhône Alpes" Area: peritoneal carcinosis and hepatocellular carcinoma.
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Hepatocellular Carcinoma | Hepatocellular Carcinoma | ONTOLOGY_EXACT | 0.98 |
| Peritoneal Carcinoma | — | UNRESOLVED | — |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| COLLAT-COVID is an observational study based on retrospective data issued from patients medial files. | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- label
- Peritoneal Carcinosis
- description
- Patients hospitalized for peritoneal carcinosis between 2017 and 2020.
- interventionNames
- Other: COLLAT-COVID is an observational study based on retrospective data issued from patients medial files.
- label
- Hepatocellular Carcinoma
- description
- Patients hospitalized for hepatocellular carcinoma between 2017 and 2020.
- interventionNames
- Other: COLLAT-COVID is an observational study based on retrospective data issued from patients medial files.
Primary outcomes (1)
- measure
- Measure of patient loss of chance when comparing a set of activity indicators between 2020 and the average activities of previous periods (2017-2019)
- timeFrame
- 24 months
- description
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Patients hospitalized in France for peritoneal carcinosis or hepatocellular carcinoma between 2017 and 2020. Exclusion Criteria: * Patients who did not allow the reuse of their medical data for research
References
Publications (0)
Data not yet available